Branded page

May 27, 2020 Partner News

Abfero Targeting Excess Iron to Treat AMD, Other Retinal Diseases

An intriguing link between excess body iron and retinal degeneration is being explored by Abfero Pharmaceuticals, a young biotech based in Boston and Oxford, UK.